The HD Labs Tirzepatide Vial 30mg is a premium dual-agonist peptide therapy designed for advanced weight management, appetite control and metabolic optimization. Developed and formulated by HD Labs, this vial contains 30mg of Tirzepatide in a convenient format suitable for structured wellness and weight-loss programs. Tirzepatide targets both GLP-1 and GIP receptors, helping reduce cravings, improve satiety and enhance metabolic efficiency.
Properties and Mechanism of Action
HD Labs Tirzepatide is a dual-agonist peptide that works by activating two key metabolic pathways:
GLP-1 receptor activation – promotes appetite suppression and improved satiety
GIP receptor activation – supports insulin sensitivity and efficient energy utilization
Supports metabolic balance – aids fat metabolism and overall metabolic function
Effects and Results
Reduced appetite and cravings
Increased feelings of fullness and improved portion control
Enhanced fat metabolism and energy regulation
Support for healthy blood sugar levels and overall metabolic function
Results may vary depending on individual lifestyle, diet and exercise.
The HD Labs Tirzepatide Vial is administered via subcutaneous injection, typically once weekly.
Recommended guidance includes:
Start with a low initial dose to support tolerability
Gradual dose escalation over several weeks
Maintain consistent weekly administration for best results
Possible Side Effects
Some individuals may experience mild to moderate side effects, particularly during dose escalation:
Nausea
Reduced appetite
Gastrointestinal discomfort (bloating, constipation, diarrhea)
Fatigue
Headache
Side effects are generally temporary and tend to subside as the body adjusts.